Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 1rare1:--Manor

Jul 31, 2007 06:04AM

Re: 1rare1:--Manor

in response to by
posted on Jul 31, 2007 07:45AM
I'm not sure what the point of your post is but, my comment had nothing to do with the Arch Conference. It was directed at a specific company listed on their link. I would suggest you take a look at them, NMKT. Much like PTSC, they weren't your ordinary penny stock either. I find there to be a strong correlation between the two in terms of the struggles they both face trying to get recoginition from the investment community. But just to expand on your comment, it sure looks like the monthly check we send Dutton has paid off, NOT...............
Share
New Message
Please login to post a reply